PharmAla Biotech to provide University of Sydney with LaNeo MDMA for clinical studies

Mugglehead
By Rowan DunneAug 31, 2022, 11:49 pm223 pts
PharmAla Biotech Holdings Inc. (CSE: MDMA) will now be supplying another major clinical trial in Australia, but the recipient of its LaNeo product will not be remaining anonymous this time. On Wednesday, the Canadian biotechnology company announced that it had been selected as the MDMA manufacturing partner…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Silk Road Drug Market Operator Pardoned By Trump Calls For More Prisoners To Be Freed, As Democrats Criticize His Clemency 66

New Jersey Officials Celebrate Completion Of Marijuana Training Academy Curriculum To Help People Enter The Legal Industry 65

Pennsylvania Governor Holds Tight to Cannabis Legalization in Budget Negotiations 62

Canadian Cannabis Sales Bounced Again 56

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.